Impact of CYP2C19 Metabolizer Status on Patients With ACS Treated With Prasugrel Versus Clopidogrel

TRILOGY ACS Investigators, Jacob A Doll, Megan L Neely, Matthew T Roe, Paul W Armstrong, Harvey D White, Dorairaj Prabhakaran, Kenneth J Winters, Suman Duvvuru, Scott S Sundseth, Joseph A Jakubowski, Paul A Gurbel, Deepak L Bhatt, E Magnus Ohman, Keith A A Fox

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Impact of CYP2C19 Metabolizer Status on Patients With ACS Treated With Prasugrel Versus Clopidogrel'. Together they form a unique fingerprint.

Neuroscience

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology

Immunology and Microbiology